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Abstract
Background: Improving child survival for HIV-infected children remains an important health agenda. We present
progress regarding care and treatment services to HIV infected children in Tanzania.
Methods: The National AIDS Control Programme Care and Treatment (CTC 2) database was used to obtain
information of all children aged 0-14yearsenrolled in the HIV Care and Treatment Program between January 2011
and December 2014. We assessed eligibility for ART, time from enrolment to ART initiation, nutritional status, and
mortality using Kaplan-Meier methods.
Results: A total of 29,531 (14,304 boys and 15,227 girls) ART-naive children aged 0–14 years were enrolled during
the period, approximately 6700 to 8000 children per year. The male to female ratio was 48:50. At enrolment 72%
were eligible for ART, 2–3% of children were positive for TB, and 2–4% were severely malnourished.
Between 2011 and 2014, 2368 (8%) died, 9243 (31%) were Lost to Follow-up and 17,920 (61%) were on care or ART.
The probability of death was 31% (95% CI 26–35), 43% (40–47), 52% (49–55) and 61% (58–64) by 1,2, 5 and 10 years
of age, respectively. The hazard of death was greatest at very young ages (<2 years old), and decreased sharply by
4 years old. Children who were on ART had around 10–15% higher survival over time.
Conclusions: Significant progress has been made regarding provision of paediatric HIV care and treatment in
Tanzania. On average 7000 children are enrolled annually, and that approximately two thirds of children diagnosed
under the age of 2 years were initiated on ART within a month. Provision of ART as soon as the child is diagnosed
is the biggest factor in improving survival. However we noted that i) most children had advanced disease at the
time of enrolment ii) approximately two-thirds of children were missing a baseline CD4 measurement and only
35% of children had either a CD4 count or percentage recorded, indicating limited access to CD4 testing services,
and iii) 31% were lost to follow-up (LTFU).
These challenges need to be addressed to improve early detection, enrolment and retention of HIV-infected
children into care and improve documentation of services offered.
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Background
The 2015 Spectrum model estimates 142,000 Tanzanian
children, under the age of 15 years, are infected with hu-
man immunodeficiency virus (HIV) [1], and current
guidelines state all should be given Antiretroviral Ther-
apy (ART) [2]. Without ART approximately 50% of HIV
infected children die before the age of two, and one-
third of those who survive past two die before 5 years of
age [3]. Improving child survival for HIV exposed and
infected children remains an important agenda in
Tanzania [4]. Promoting universal access to available
HIV care and treatment services is important for im-
proving survival of HIV-infected individuals, especially
children [5].
The encouraging success of ART, which includes ef-
fective prevention of mother-to-child transmission, has
led to ambitious calls to eliminate HIV as a public health
threat by 2030 [6]. Achievement of these goals, including
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the United Nations Programme on HIV/AIDS
(UNAIDS) 90–90-90 targets, which aim to have 90% of
people living with HIV know their status, 90% of those
detected treated with ART, and 90% of those receiving
treatment achieving viral load suppression [7], requires a
coordinated global scale-up of prevention programmes,
pre-exposure prophylaxis (PrEP), and detection and
treatment programmes [8].
On its part, the government of the United Republic of
Tanzania has laid out goals aiming at zero new HIV in-
fections, zero discrimination and zero HIV related
deaths in the population, including children, by 2017 [9].
These goals guide interventions that contribute to im-
proving access to HIV services, especially for vulnerable
groups like children.
It is well known that universal access to HIV care and
treatment services contributes to improved quality of
life, and thus economic, social and political development
of society [10], which is in keeping with the United Na-
tions (UN) sustainable goals number 3 [11]. The Na-
tional AIDS Control Programme (NACP) in Tanzania is
aiming at providing antiretroviral medicines (ARVs) to
People Living with HIV and AIDS (PLHIV). The main
focus is to improve access to ART services in order to
reduce HIV related morbidity and mortality, especially
among children. Due to this, Ministry of Health in
Tanzania requires that paediatric HIV statistics be made
available and utilized for policy and decision-making.
This report summarizes progress made in providing HIV
care and treatment services to children in Tanzania and
highlights challenges in achieving universal access for
ART to HIV-infected children. The information in this
report contributes to the monitoring of Pediatric HIV
and AIDS program in Tanzania.
Methods
Design, setting and population
This was a descriptive analytical study based on NACP
data of children aged 0–14 that was routinely collected
from 740 HIV care and treatment service delivery clinics
between 2011 and 2014 and archived in the NACP data-
base, where data was extracted.
Data management and analysis
Primary data generated in the HIV care and treatment
clinics (CTC) was captured on facility-held information
collection tools designated as CTC-2 card. This was sub-
mitted on quarterly basis to national level at NACP in
either paper form or electronic system, and subsequently
entered in the national care and treatment database des-
ignated as CTC-3. The CTC-3 database contains both
patient-level section (CTC-3 Macro), exported electron-
ically from clinics using an electronic CTC-2 database
and aggregate-level section (CTC-3) that contains data
receive quarterly summary reports either paper based or
extracted from the CTC-2 data. Data analysis was per-
formed using Stata version 14 [12].
Eligibility for ART
We determined eligibility of children for ART based on
WHO staging or CD4 results and estimated the time
from enrolment to ART initiation. Results for eligibility
for ART are restricted to 2012 onwards, since the na-
tional guidelines changed in 2012, which advocate initi-
ation of ART regardless of World Health Organization
(WHO) clinical stage and CD4 cell count [13]. The pre-
vious eligibility criteria, before the 2012 guidelines, was
CD4 < 25% or WHO stage 3 and 4. A window of −90 to
+30 days relative to the date of ART start was allowed to
capture characteristics at ART start choosing that closest
measurement to ART start, with preference for before.
Assessment of nutritional status
Nutritional status of children was assessed over time using
weight and length or height for age. The nutrition status
was translated using Z-score criteria of Weight for age
and weight for length/Height. Time was categorized into 3
monthly periods and the highest non-missing nutritional
status for each child in each 3 months period was used.
Estimation of mortality
Mortality was estimated using Kaplan-Meier methods
from date of birth, with entry into the risk set from the
time of enrolment through death. Lost to follow up
(LTFU) was defined if a child was not seen within the
6 months before the end of December 2014 and cen-
sored at their last visit date. Children who had not died
and were not defined as LTFU were considered to be in
follow up through to the analysis censoring date of 31
December 2014 and were censored at that time. Chil-
dren were defined as No Longer On Treatment (NLOT)
if they had either died or were LTFU.
Ethical consideration and approval
Data used in this analysis was collected routinely by
health facilities providing HIV care and treatment ser-
vices following the National Guidelines for HIV Care
and Treatment, in which ethical issues are strongly ad-
vocated. Permission to analyse and publish this data was
granted by the Ministry of Health, Community Develop-
ment, Gender, Elderly and Children (MoHCDGEC).
Management of the data was under strict supervision
the Epidemiology Unit of NACP.
Results
Children characteristics at CTC enrolment
A total of 29,531 (14,304 (48%) boys and 15,227 (52%)
girls) ART-naive children aged 0–14 years were enrolled
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between 2011 and 2014, which is approximately 6700 to
8000 children per year. The characteristics of enrolees
are shown in Table 1.
Of the 29,531 children enrolled in care, a total of
10,390 (35%) were in WHO stage III and 3196 (11%)
were in WHO stage IV (Table 1). The proportion of
children with CD4 count <50 cells/mm3 decreased in
2014 compared to earlier years (4.3% in 2014 versus
5.9% overall). However, approximately two-thirds of
children across all years were missing a baseline CD4
absolute count. The proportion of children missing
CD4 percentage data was even higher, at nearly 100%
overall. Only 35% of children had either a CD4 count
or percentage recorded.
The most common referral point was voluntary coun-
selling and testing (VCT) (18% overall), followed by pro-
vider initiated testing and counselling (PITC) (12%).
However, 65% of children did not have their referral
point recorded (Table 2).
Approximately 2–3% of children were identified at en-
rolment as being positive for TB and this was fairly con-
stant across the years (Table 2). TB screening was done
using a standardized TB screening tool (annex). All chil-
dren <5 years old are given cotrimoxazole and for
>5 years with CD4 cell count below 350. The proportion
of children on cotrimoxazole over the years has also
remained fairly constant, at 70–74%. In earlier years, the
nutritional status of children at enrolment was not con-
sistently captured (22% missing in 2011 and 50% missing
in 2012). In 2014, the missing data was a lot lower
(10%). Across all years, the majority of children were not
malnourished, with only 2–4% recorded as being severe
malnourished (Table 2).
Eligibility at enrolment and time to starting ART
Among the 21,503 children enrolled in 2012–2014,
15,522 (72%) were eligible for ART from enrolment
(Table 3). However, 4624 (22%) had unknown eligibility,
Table 1 Baseline characteristics of 29,531 children enrolled into HIV care services between 2011 and 2014
2011 2012 2013 2014 Total
Total (row %) 8028 (27.2%) 6727 (22.8%) 7171 (24.3%) 7605 (25.8%) 29,531 (100%)
Sex Male 3913 (48.7%) 3262 (48.5%) 3418 (47.7%) 3711 (48.8%) 14,304 (48.4%)
Female 4115 (51.3%) 3465 (51.5%) 3753 (52.3%) 3894 (51.2%) 15,227 (51.6%)
WHO stage Stage I 2083 (25.9%) 1732 (25.7%) 1685 (23.5%) 1713 (22.5%) 7213 (24.4%)
Stage II 2417 (30.1%) 1838 (27.3%) 1934 (27.0%) 2045 (26.9%) 8234 (27.9%)
Stage III 2420 (30.1%) 2240 (33.3%) 2686 (37.5%) 3044 (40.0%) 10,390 (35.2%)
Stage IV 917 (11.4%) 805 (12.0%) 768 (10.7%) 706 (9.3%) 3196 (10.8%)
Missing 191 (2.4%) 112 (1.7%) 98 (1.4%) 97 (1.3%) 498 (1.7%)
Weight, kg <10 2121 (26.4%) 1850 (27.5%) 1845 (25.7%) 1850 (24.3%) 7666 (26.0%)
10- < 20 3129 (39.0%) 2542 (37.8%) 2855 (39.8%) 3003 (39.5%) 11,529 (39.0%)
20- < 30 1582 (19.7%) 1316 (19.6%) 1442 (20.1%) 1532 (20.1%) 5872 (19.9%)
> = 30 934 (11.6%) 814 (12.1%) 801 (11.2%) 933 (12.3%) 3482 (11.8%)
Missing 262 (3.3%) 205 (3.0%) 228 (3.2%) 287 (3.8%) 982 (3.3%)
CD4 cell count, cells/mm3 <50 488 (6.1%) 467 (6.9%) 460 (6.4%) 330 (4.3%) 1745 (5.9%)
50–199 627 (7.8%) 688 (10.2%) 710 (9.9%) 681 (9.0%) 2706 (9.2%)
> = 200 1404 (17.5%) 1444 (21.5%) 1472 (20.5%) 1444 (19.0%) 5764 (19.5%)
Missing 5509 (68.6%) 4128 (61.4%) 4529 (63.2%) 5150 (67.7%) 19,316 (65.4%)
CD4 percentage, % <25 63 (0.8%) 21 (0.3%) 0 (0.0%) 0 (0.0%) 84 (0.3%)
> = 25 20 (0.2%) 4 (0.1%) 0 (0.0%) 0 (0.0%) 24 (0.1%)
Missing 7945 (99.0%) 6702 (99.6%) 7171 (100.0%) 7605 (100.0%) 29,423 (99.6%)
Measurement of CD4 count or percent Have at least one 2577 (32.1%) 2619 (38.9%) 2642 (36.8%) 2455 (32.3%) 10,293 (34.9%)
Missing both 5451 (67.9%) 4108 (61.1%) 4529 (63.2%) 5150 (67.7%) 19,238 (65.1%)
Facility type Dispensary 815 (10.2%) 929 (13.8%) 1206 (16.8%) 1477 (19.4%) 4427 (15.0%)
Health centre 2395 (29.8%) 2129 (31.6%) 2418 (33.7%) 2750 (36.2%) 9692 (32.8%)
Hospital 4366 (54.4%) 3354 (49.9%) 3297 (46.0%) 3155 (41.5%) 14,172 (48.0%)
Other 437 (5.4%) 301 (4.5%) 224 (3.1%) 199 (2.6%) 1161 (3.9%)
Missing 15 (0.2%) 14 (0.2%) 26 (0.4%) 24 (0.3%) 79 (0.3%)
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mainly due to either being categorized as WHO stage I
or II or missing CD4 count or percentage. The propor-
tion with unknown eligibility was slightly lower among
older compared to younger children except for <2 year
olds, who were all eligible for treatment initiation re-
gardless of WHO staging or CD4 results.
Among <2 year olds, who should all start treatment im-
mediately regardless of WHO stage or CD4 results, 41%
initiated treatment on the day of enrolment into CTC care,
and a further 24% initiated within 1 month of enrolment
(Table 4). However, around 7% started treatment >3 months
after enrolment, and 21% had not started treatment at all.
ART initiation by age
A total of 15,805 children were observed to initiate ART
by the end of December 2014 (Table 4). The proportion
by age were 13% aged <1 year, 36.2% aged 1–4 years,
26.6% aged 5–9 years, 20.6% aged 10–14 years and <1%
aged 14 + years (Table 5).
Nutritional status
Figure 1 shows the nutritional status of children over
time from ART initiation. The declining bars show that
fewer children are being followed up for long after ART
initiation. Overall most children were not malnourished,
and there was little severe malnutrition observed after
3 months on ART.
Mortality of children
Among 29,531 children enrolled in 2011–2014, 2368
(8%) were known to have died, 9243 (31%) were consid-
ered LTFU and 17,920 (61%) were still under active fol-
low up. Fig. 2 shows the survival probability over age.
The probability of death by 1 year of age was 31% (95%
CI 26–35), by 2 years of age was 43% (40–47), by 5 years
of age was 52% (49–55) and by 10 years of age was 61%
(58–64). The hazard of death was greatest at very young
ages (<2 years old), decreased sharply by 4 years old and
then plateaued, with relatively constant hazard from 4 to
10 years old (Fig. 3).
Children who were on ART had around 10–15%
higher survival over time (Fig. 4). The hazard was sub-
stantially higher among younger chilren not on ART
compared to those on ART (Fig. 5). However, from
4 years of age onwards, there was little difference in the
hazards between children irrespective of ART status.
Discussion
Our results show that the number of children enrolled
into HIV care and treatment programme per year is
Table 2 Referral sources, prophylaxis and nutritional status of 29,531 children enrolled into care between 2011 and 2014
Referral source 2011 2012 2013 2014 Total
HBC 48 (0.6%) 28 (0.4%) 38 (0.5%) 23 (0.3%) 137 (0.5%)
PITC 894 (11.1%) 748 (11.1%) 934 (13.0%) 1040 (13.7%) 3616 (12.2%)
PMTCT 330 (4.1%) 310 (4.6%) 285 (4.0%) 364 (4.8%) 1289 (4.4%)
VCT 1524 (19.0%) 1329 (19.8%) 1287 (17.9%) 1284 (16.9%) 5424 (18.4%)
Missing 5232 (65.2%) 4312 (64.1%) 4627 (64.5%) 4894 (64.4%) 19,065 (64.6%)
Positive for TB No 27,658 (93.7%) 7359 (91.7%) 6251 (92.9%) 6780 (94.5%) 7268 (95.6%)
Yes 672 (2.3%) 117 (1.5%) 149 (2.2%) 211 (2.9%) 195 (2.6%)
Missing 1201 (4.1%) 552 (6.9%) 327 (4.9%) 180 (2.5%) 142 (1.9%)
Cotrimoxazole No 7977 (27.0%) 2264 (28.2%) 2026 (30.1%) 1835 (25.6%) 1852 (24.4%)
Yes 21,554 (73.0%) 5764 (71.8%) 4701 (69.9%) 5336 (74.4%) 5753 (75.6%)
Malnourished No 19,172 (64.9%) 3370 (42.0%) 4540 (67.5%) 5272 (73.5%) 5990 (78.8%)
Mild 3 (0.0%) 3 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
Moderate 3005 (10.2%) 453 (5.6%) 806 (12.0%) 911 (12.7%) 835 (11.0%)
Severe 906 (3.1%) 158 (2.0%) 268 (4.0%) 259 (3.6%) 221 (2.9%)
Missing 6445 (21.8%) 4044 (50.4%) 1113 (16.5%) 729 (10.2%) 559 (7.4%)
Table 3 Eligibility for ART initiation by age at enrolment
Age category II, years <2 2–5 6–9 10–14 Total
Eligible 6073 (100%) 3840 (61%) 2855 (60%) 2754 (63%) 15,522 (72%)
Not eligible 0 317 (5%) 603 (13%) 437 (10%) 1327 (6%)
Unknown eligibility 0 2088 (33%) 1326 (28%) 1210 (27%) 4624 (22%)
Total 6073 (100%) 6245 (100%) 4784 (100%) 4401 (100%) 21,503 (100%)
Somi et al. BMC Health Services Research  (2017) 17:540 Page 4 of 8
between 6700 and 8000 and that the proportion of girls
is slightly higher compared to boys. Almost 72% of the
enrolled children were eligible for ART at the time of en-
rolment, and that almost half (46%) were in WHO stages
III and IV, indicative of advanced disease stage. Mortality
rate among the enrolees was about 8%, and the hazard
was substantially higher among younger children not on
ART compared to those on ART.
Provision of ART as soon as the child is diagnosed is
the biggest factor in improving survival, with a hazard of
mortality in the first year of life, at 15% for children on
ART, compared to 26% for children not on ART. Chil-
dren who were on ART had around 10–15% higher sur-
vival over time. However, from 4 years of age onwards,
there was little difference in the hazards between chil-
dren irrespective of ART status. It is likely that children
who reach older ages without having started treatment
are likely to be be “long term non-progressors”, refering
to individuals who are infected with HIV, but maintain a
CD4 count greater than 500 without antiretroviral ther-
apy with a detectable viral load [14].
The benefits of ART observed in this study have
been demonstrated in several studies showing signifi-
cant reduction mortality with early ART initiation,
within the first 12 weeks of life [15–23], accompanied
with a greater than 90% probability of survival into
adulthood [24].
Our study revealed a number of significant challenges
that need considerable attention by National AIDS
Control Programme and other stakeholders involved in
the provision of paediatric HIV care and treatment ser-
vices in Tanzania. We noted that i) most children have
advanced disease at the time of enrolment ii) approxi-
mately two-thirds of children were missing a baseline
CD4 measurement and only 35% of children had either
a CD4 count or percentage recorded, indicating limited
access to CD4 testing services, and iii) 31% were lost to
follow-up (LTFU).
It is therefore a critical public health priority to ad-
dress these challenges for a successful expansion of
paediatric HIV care and treatment services in Tanzania.
Strategies for early diagnosis of HIV-infected children
and linking them to care and treatment services are es-
sential. Besides this, minimizing the current attrition
rates, which have also been observed in clinical settings
across all HIV programs in Africa, with overall attrition
rates ranging from 10% to more than 50% at 24 months
[25–30], mainly because of loss to follow-up (LTFU) or
AIDS-related death [27, 31]. One possible explanation of
the high rates of LTFU could associated with the quality
of the data collection and reporting systems, which is a
common challenge of health information systems in
resource-limited settings [32–34]. Improving capacity
for systematic monitoring and accurate reporting may
reduce the number of patients LTFU, particularly for
sites that rely on paper-based monitoring systems.
Despite these challenges it was encouraging to note
that majority of children had good nutrition status, with
Table 4 Time from enrolment to ART initiation by age
<2 2–5 6–9 10–14 Total
Enrolment 2468 (40.6%) 1398 (22.4%) 874 (18.3%) 753 (17.1%) 5493 (25.5%)
Within 1 month 1439 (23.7%) 1583 (25.3%) 1318 (27.6%) 1468 (33.4%) 5808 (27.0%)
Within 2 months 316 (5.2%) 426 (6.8%) 346 (7.2%) 330 (7.5%) 1418 (6.6%)
Within 3 months 150 (2.5%) 185 (3.0%) 148 (3.1%) 172 (3.9%) 655 (3.0%)
Within 6 months 196 (3.2%) 288 (4.6%) 270 (5.6%) 200 (4.5%) 954 (4.4%)
Within 12 months 142 (2.3%) 275 (4.4%) 239 (5.0%) 195 (4.4%) 851 (4.0%)
>12 months 90 (1.5%) 220 (3.5%) 179 (3.7%) 137 (3.1%) 626 (2.9%)
Not yet started 1272 (20.9%) 1870 (29.9%) 1410 (29.5%) 1146 (26.0%) 5698 (26.5%)
Total 6073 (100%) 6245 (100%) 4784 (100%) 4401 (100%) 21,503 (100%)
Table 5 ART initiation by age
2012 2013 2014 Total
Age 3876 (24.5%) 5488 (34.7%) 6441 (40.8%) 15,805 (100%)
Age category I <1 631 (16.3%) 681 (12.4%) 745 (11.6%) 2057 (13.0%)
1–4 1403 (36.2%) 2065 (37.6%) 2506 (38.9%) 5974 (37.8%)
5–9 1031 (26.6%) 1562 (28.5%) 1764 (27.4%) 4357 (27.6%)
10–14 797 (20.6%) 1146 (20.9%) 1363 (21.2%) 3306 (20.9%)
>14a 14 (0.4%) 34 (0.6%) 63 (1.0%) 111 (0.7%)
a Captured aged <15 years at enrolment but became >14 years old before starting treatment
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only 2–4% of children severely malnourished and that
nutritional status improved with time on ART. Further-
more, only 2–3% of children were diagnosed with TB at
the time of enrolment and that the proportion of chil-
dren on Cotrimoxazole was high (70–74%).
Limitations of the study
This report has analysed a large amount of data from
across Tanzania, but there are several limitations to our
findings. One limitation is that the data come from the
electronic, CTC database, which is used in the larger and
better run clinics. The situation reported here might not
be the same in smaller health facilities that have not pro-
vided electronic data. Secondly the data are dependent on
the self-reporting of conditions (such as opportunistic in-
fections) by patients, and the recording of such data by cli-
nicians and nurses. The amount of missing data has been
reduced over the past 5 years but it is still a problem.
We have used basic statistical methods to analyse
these data. Some of the assumptions around independ-
ence may not be valid in the analysis of these data,
especially in the treatment of missing data (which is
likely to be correlated with the outcomes). We have used
a competing risks analysis of the mortality pre-ART,
which is a first step in acknowledging these concerns
about the use of basic statistical methods. However fur-
ther work needs to be done about the theoretical under-
pinnings of the statistical methods used for the analysis
of routinely collected data.
Despite its limitations, this review has provided some
insights in to the achievements and gaps in clinical ser-
vices for paediatric HIV care and treatment in Tanzania
and does suggest areas that could be strengthened to im-
prove these services.
Conclusions
Significant progress has been made regarding provision
of paediatric HIV care and treatment in Tanzania. On
average 7000 children are enrolled annually, and that ap-
proximately two thirds of children diagnosed under the
age of 2 years were initiated on ART within a month.
Provision of ART as soon as the child is diagnosed is the
Fig. 1 Nutritional status of children over time from ART initiation
Fig. 2 Survival of HIV positive children from birth (age in years)
Fig. 3 Hazard from birth in HIV positive children (age in years)
Fig. 4 Survival from birth, in HIV positive children, by ART status
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biggest factor in improving survival, with a hazard of
mortality in the first year of life, at 15% for children on
ART, compared to 26% for children not on ART. How-
ever we noted that i) most children had advanced dis-
ease at the time of enrolment ii) approximately two-
thirds of children were missing a baseline CD4 measure-
ment and only 35% of children had either a CD4 count
or percentage recorded, indicating limited access to CD4
testing services, and iii) 31% were lost to follow-up
(LTFU). These challenges underscore the need for more
aggressive strategies to increase enrolment and retention
of children in such settings. Evidently more work is
needed to link HIV-infected children to HIV services.
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